Drug Topics

JANUARY 7, 2025

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Vaccines 210

Vaccines Immunization 210

IDStewardship

JANUARY 8, 2025

In this article, five key skills for pharmacy residents are identified and discussed. Authored by:Asma Alamri, Pharm.D. &Huda Almalki, Pharm.D. Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D., BCPS, BCIDP, AAHIVP System-Wide Post-Graduate Year-1Pharmacy Residency Program Director, Taif Health Cluster, Saudi Arabia UNDER CONSTRUCTION Article Posted January 2024 According to the American College of Clinical Pharmacy (ACCP a reside

Health and Personal Care Stores 130

Health and Personal Care Stores Patient Care Hospitals 130

STAT

JANUARY 6, 2025

After nearly a decade of machine learning innovation in the drug industry, the Food and Drug Administration Monday published its first draft guidance on the use of artificial intelligence in the development of drugs and biological products. The guidance comes as drug regulatory submissions citing AI have increased exponentially. In an interview with STAT in October, the FDA’s Tala Fakhouri, who co-leads the Center for Drug Evaluation and Research’s AI Council, said the agency has r

FDA 138

FDA 138

Pharmacy Times

JANUARY 10, 2025

As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JANUARY 9, 2025

Hippocratic AI is kicking off 2025 with a bang. The startup, which is building a large language model specifically for healthcare use cases, banked a $141 million series B financing round only nine months after its series A round.

140

140

PharmaVoice

JANUARY 6, 2025

How regulators could hit PBMs from multiple sides in the coming year.

130

130

IDStewardship

JANUARY 13, 2025

In this article an infectious diseases pharmacist discusses five interesting things to know about sulopenem (Orlynvah). Authored by: Tina Zheng, Pharm.D., BCIDP UNDER CONSTRUCTION Article PostedXXX Sulopenem etzadroxil and probenecid (Orlynvah) was recently approved in October 2024 for the treatment of uncomplicated urinary tract infections (uUTI) caused by Escherichia coli , Klebsiella pneumoniae , or Proteus mirabilis.

Packaging 130

Packaging Labelling FDA 130

STAT

JANUARY 12, 2025

The Justice Department is interviewing former UnitedHealth Group physicians about their experiences working at practices owned by the health care giant, two sources with knowledge of the inquiries told STAT.

Insurance 145

Insurance 145

Pharmacy Times

JANUARY 6, 2025

The patient was hospitalized after exposure to an infected backyard flock.

Hospitals 144

Hospitals 144

Fierce Healthcare

JANUARY 3, 2025

Mimicking prior federal and state investigations into drug manufacturers, health insurer Aetna is suing in Connecticut for rigging the generic drug market.

Insurance 145

Insurance 145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

JANUARY 3, 2025

Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its

109

109

Drug Topics

JANUARY 7, 2025

The individual who first reported severe bird flu and hospitalization has since succumbed to their illness.

Hospitals 186

Hospitals 186

PharmaVoice

JANUARY 2, 2025

A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.

128

128

STAT

JANUARY 8, 2025

SAN FRANCISCO — Next week brings the return of the J.P. Morgan Healthcare Conference, and with it another fabled opportunity for companies in the industry to court possible mergers, acquisitions, and licensing deals. This year, there will be even greater pressure to make a good match, as the pharmaceutical industry, which drives more than $1 trillion in economic activity and thousands of jobs, faces one of the largest patent cliffs in recent history.

144

144

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 2, 2025

Over 70% of children and young people with long COVID reported improvements in their symptoms within 24 months of their initial positive SARS-CoV-2 test.

145

145

Fierce Healthcare

JANUARY 2, 2025

In this month's payer roundup, CVS faces antitrust questions from Congress as the company lays off more workers following a failed Medicaid bid in Kansas, Oscar Health CEO Mark Bertolini has a bold idea to remake health insurance and Johnson & Johnson is suing Express Scripts in a long-running lawsuit.

Insurance 142

Insurance 142

European Pharmaceutical Review

JANUARY 7, 2025

The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.

FDA 105

FDA Patient Care 105

Drug Topics

JANUARY 6, 2025

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.

FDA 187

FDA 187

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

JANUARY 9, 2025

Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.

111

111

STAT

JANUARY 6, 2025

Americans want Medicaid. The waiting list to receive home- and community-based services through the state-federal health program has hovered around 700,000 people in recent years. A line that long would stretch from Cleveland to Chicago. The queue may get longer.

145

145

Pharmacy Times

JANUARY 8, 2025

Data from a follow-up at 6 months show a reduced risk of all-cause mortality in heart attack patients with anemia who receive a liberal transfusion strategy compared with a restrictive one.

139

139

Fierce Healthcare

JANUARY 8, 2025

Healthcare tech company H1 picked up Ribbon Health, a provider data management software company to broaden its reach into the health plan, provider system and digital health sectors.

133

133

pharmaphorum

JANUARY 2, 2025

The challenges facing oncology clinical trials are multifaceted, but there is a clear opportunity for pharmaceutical companies to rethink their approach to clinical research, and prioritise the patient from the beginning.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies 115

Drug Topics

JANUARY 3, 2025

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Vaccines 185

Vaccines Immunization 185

PharmaVoice

JANUARY 8, 2025

A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.

110

110

STAT

JANUARY 10, 2025

In an apparently unprecedented move, Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money. Most drug companies have venture funds, which they use both to make investments and to scout out potentially important scientific and technological trends. But it is unusual for a drug giant to co-manage a fund with an existing venture capital firm, or for a venture capital fund to source its capital from a

145

145

Pharmacy Times

JANUARY 7, 2025

Despite these concerns, experts have emphasized that the benefits of RSV vaccination outweigh potential risks for older adults, who are at heightened risk of severe RSV-related illness.

Vaccines 139

Vaccines FDA 139

Fierce Healthcare

JANUARY 6, 2025

A Louisiana patient who had been hospitalized with the first human case of highly pathogenic avian influenza, or H5N1, in Louisiana and the U.S. has died, the state's health department reported Monday.

Hospitals 130

Hospitals 130

pharmaphorum

JANUARY 7, 2025

The FDA has placed the credibility of AI's 'context of use' in pharma development at the heart of its first guidance in this area

FDA 111

FDA 111

Drug Topics

JANUARY 8, 2025

Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.

148

148

The Checkup by Singlecare

JANUARY 3, 2025

Contrave is a brand-name medication approved by the U.S. Food and Drug Administration (FDA) for chronic (long-term) weight management in certain adults. It should be taken with a reduced-calorie diet and increased physical activity. As a combination drug that contains an opioid antagonist and antidepressant, it affects the brain to make you feel fuller and lower your appetite.

FDA 96

FDA 96

STAT

JANUARY 10, 2025

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we do plan to promenade with the official mascots, catch up on our reading and hold a listening party with Mrs. Pharmalot, where the rotation will likely include this , this , this , this and this.

Independent Pharmacies 109

Independent Pharmacies 109

Pharmacy Times

JANUARY 7, 2025

Approximately 61% of individuals said respiratory syncytial virus (RSV vaccination for adults 60 years and older is effective.

Vaccines 139

Vaccines 139